Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
This study is currently recruiting participants.
Verified September 2012 by Bioniche Pharma USA LLC
Sponsor:
Bioniche Pharma USA LLC
Information provided by (Responsible Party):
Bioniche Pharma USA LLC
ClinicalTrials.gov Identifier:
NCT01152346
First received: June 25, 2010
Last updated: September 10, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2012 |
| Estimated Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |